Several leading medical organizations have released updated recommendations for flu, COVID-19, and respiratory syncytial virus (RSV) vaccines for the 2026-27 respiratory season. The guidance, available through the Vaccine Integrity Project, can help people with vitiligo make informed decisions about respiratory virus protection.
Vitiligo is an autoimmune condition in which the immune system attacks cells that give skin its color. Unlike some other autoimmune conditions, vitiligo itself doesn’t generally affect overall physical health or automatically mean someone has weakened defenses against infection.
However, some people with vitiligo have other autoimmune conditions, and their treatment or other health conditions may influence their vaccination needs.
Vaccines train the immune system to recognize and fight specific viruses. This can help your body respond more quickly if you’re exposed to them.
There isn’t one vaccine plan that’s right for everyone with vitiligo. Your age, treatment plan, immune function, vaccination history, and other health conditions can all influence which vaccines are recommended and when you should receive them.
The Vaccine Integrity Project, working with the American Medical Association, reviewed the latest evidence on flu, COVID-19, and RSV immunizations for the 2026-27 respiratory season. The findings helped inform recommendations from several leading medical organizations, including:
The review included 299 studies published mostly between August 2025 and June 2026. It found that flu, COVID-19, and RSV immunizations continued to provide meaningful protection against hospitalization, severe illness, and death.
The amount of protection can vary based on the virus, the vaccine or immunization, the season, and a person’s health. For people with vitiligo, vaccination decisions should take into account factors such as age, other health conditions, and whether any treatment affects immune function.
For the 2026-27 respiratory season, COVID-19 and flu vaccines have updated formulations. There are also three RSV vaccines for adults. These vaccines differ in how they are made and which age groups or risk groups they are approved for.
The U.S. Food and Drug Administration (FDA) has approved four COVID-19 vaccine options. All four vaccines are given by injection.
The IDSA recommends that people with weakened immune systems discuss receiving a second dose of the COVID-19 vaccine two to six months after the first dose.
All U.S. flu vaccines for the 2026-27 season are trivalent, meaning they are designed to protect against three influenza viruses.
Most people need one flu vaccine dose each season. Some children may need a second dose based on their age, vaccination history, or individual health circumstances.
For people with vitiligo, flu vaccine timing generally follows standard recommendations unless another health condition or treatment calls for special consideration.
People who are immunocompromised shouldn’t receive the live-attenuated nasal flu vaccine FluMist, per guidance from the U.S. Centers for Disease Control and Prevention (CDC) and IDSA.
There are three FDA-approved adult RSV vaccines.
For adults, the CDC recommends a single dose of RSV vaccine for everyone age 75 and older and for adults ages 50 through 74 who are at increased risk of severe RSV illness.
For people who are immunocompromised because of another condition or treatment, the IDSA recommends RSV vaccination starting at age 18. Having vitiligo doesn’t, on its own, mean that a person is immunocompromised.
The RSV vaccine isn’t currently given every year.
For people who are immunocompromised, the benefits of vaccination generally outweigh the risks. Current evidence shows that flu, COVID-19, and RSV immunizations can reduce hospitalization, severe illness, and death. People with weakened immune systems may not respond as strongly to vaccines, but vaccination can still provide protection.
Vaccines can cause side effects, but serious side effects are uncommon. Your healthcare team can explain what to expect and help you weigh the benefits and risks based on your:
The right vaccine and timing can vary for people with vitiligo. Vitiligo is an autoimmune condition, but on its own, it doesn’t mean that the immune system is too weak to fight infections. Having vitiligo doesn’t automatically place you in a higher-risk category for severe respiratory infections or mean you need a different vaccine schedule.
It’s important to ask not only which products are available, but which type, dose, and timing make sense for you.
Your healthcare team may consider:
Some vaccine types may not be appropriate for people with weakened immune systems. For example, the nasal spray flu vaccine is a live vaccine and shouldn’t be used by people who are immunocompromised. Having vitiligo alone doesn’t automatically mean you’re immunocompromised.
Timing may also matter. Vitiligo treatments can include medicated creams and light therapy. These treatments generally don’t require changes to vaccine timing.
However, certain medicines that suppress the immune system throughout the body may affect when you should receive vaccines.
If you take medicines that suppress your immune system throughout your body, such as oral corticosteroids or certain other immune-suppressing drugs, your healthcare team can help determine whether vaccine type or timing needs to change.
Your dermatologist or other healthcare professional can recommend vaccine timing based on your treatment and overall health. Don’t delay, skip, or change vitiligo treatment to get vaccinated unless your healthcare team recommends it.
People with weakened immune systems may not develop as strong a response to vaccines as people with healthy immune systems. That doesn’t mean vaccination has no benefit.
The Vaccine Integrity Project found that respiratory-virus immunizations continued to reduce severe outcomes among people with immunocompromising conditions, although protection varied.
In many cases, COVID-19, flu, and RSV vaccines can be given at the same visit.
Whether that makes sense for you may depend on your treatment schedule, previous vaccinations, expected side effects, and other health needs. Ask your healthcare team whether getting more than one vaccine at the same appointment is appropriate.
Get updates directly to your inbox.
Become a member to get even more
This is a member-feature!
Sign up for free to view article comments.
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.